MiNK-215, an IL-15 Armored FAP-Targeting CAR iNKT Cell Therapy, Effectively Treats Human Organoid Models of Treatment-Refractory MSS Colorectal Cancer (CRC) Liver Metastases

Time: 1:45 pm
day: Day One


  • Exploring methods for validating liver organoid models to ensure accurate representation of the liver metastases tumor microenvironment
  • Optimizing Organoid – immune cell co-culture for use in immune-oncology
  • Screening combination therapies